Covered recipient · General Payments record
LISET N STOLETNIY
Allopathic & Osteopathic Physicians Internal Medicine Advanced Heart Failure and Transplant Cardiology
General Payments · PY2019–2024
$1,165.45
- Reported across 22 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $163.72 | 10 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $71.32 | 4 |
| E.R. Squibb & Sons, L.L.C. | $45.35 | 3 |
| Medtronic, Inc. | $16.21 | 1 |
| Lexicon Pharmaceuticals, Inc. | $15.84 | 1 |
| Acerta Pharma LLC | $15.00 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $15.00 | 01/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104414747 | CMS |
| E.R. Squibb & Sons, L.L.C. | $16.15 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101372916 | CMS |
| E.R. Squibb & Sons, L.L.C. | $15.62 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101372926 | CMS |
| E.R. Squibb & Sons, L.L.C. | $13.58 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101372928 | CMS |
| Lexicon Pharmaceuticals, Inc. | $15.84 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1081724623 | CMS |
| Medtronic, Inc. | $16.21 | 01/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119369571 | CMS |
| Novo Nordisk Inc | $19.49 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096964050 | CMS |
| Novo Nordisk Inc | $16.98 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096811659 | CMS |
| Novo Nordisk Inc | $15.68 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096751633 | CMS |
| Novo Nordisk Inc | $19.17 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096616984 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.